Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Surgical Procedures, Operative × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Sarcoma 4 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Glioblastoma 3 Breast Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Neoplasms 2 Melanoma 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pilonidal Sinus 1 Patient Preference 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1

Interventions

pembrolizumab 20 enfortumab vedotin 12 Magnetic Resonance Spectroscopy 9 avelumab 8 Specimen Handling 8 Nivolumab 8 Gemcitabine 7 Cisplatin 7 atezolizumab 6 Carboplatin 6 sacituzumab govitecan 4 Ipilimumab 4 Docetaxel 4 durvalumab 3 lenvatinib 2 dodecyl maltoside 2 cabozantinib 2 Paclitaxel 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1 tislelizumab 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡